ORIC Pharmaceuticals, Inc. (ORIC) Misses Q4 EPS by 1c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q4 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• KeyBanc Starts Celanese (CE) at Overweight
• RH (RH) Tops Q2 EPS by $2.31